These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7753964)

  • 1. Behavioral studies on FR115427, a novel selective N-methyl-D-aspartate antagonist.
    Nakanishi H; Katsuta K; Ueda Y; Takasugi H; Kuno A; Ohkubo M; Ogita K; Yoneda Y; Shirakawa K; Yoshida K
    Psychopharmacology (Berl); 1995 Jan; 117(2):172-7. PubMed ID: 7753964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of the binding of [3H]FR115427, a novel non-competitive NMDA receptor antagonist, to rat brain membranes.
    Sherriffs HJ; Shirakawa K; Kelly JS; Olverman HJ; Kuno A; Okubo M; Butcher SP
    Eur J Pharmacol; 1993 Nov; 247(3):319-24. PubMed ID: 8307103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the patterns of altered cerebral glucose utilisation produced by competitive and non-competitive NMDA receptor antagonists.
    Sharkey J; Ritchie IM; Butcher SP; Kelly JS
    Brain Res; 1996 Sep; 735(1):67-82. PubMed ID: 8905171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical and electrophysiological studies on FR115427, a novel non-competitive NMDA receptor antagonist.
    Hodgkiss JP; Sherriffs HJ; Cottrell DA; Shirakawa K; Kelly JS; Kuno A; Ohkubo M; Butcher SP; Olverman HJ
    Eur J Pharmacol; 1993 Aug; 240(2-3):219-27. PubMed ID: 7902282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-competitive NMDA antagonists, FR115427 and MK801, enhance neuronal survival in primary culture.
    Ueda Y; Katsuta K; Nakanishi H; Yoshida K
    Neurosci Lett; 1995 Feb; 185(2):107-10. PubMed ID: 7746498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on cerebral protective agents. IX. Synthesis of novel 1,2,3,4-tetrahydroisoquinolines as N-methyl-D-aspartate antagonists.
    Ohkubo M; Kuno A; Katsuta K; Ueda Y; Shirakawa K; Nakanishi H; Nakanishi I; Kinoshita T; Takasugi H
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):95-102. PubMed ID: 8582046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional variations in [3H]MK801 binding to rat brain N-methyl-D-aspartate receptors.
    Reynolds IJ; Palmer AM
    J Neurochem; 1991 May; 56(5):1731-40. PubMed ID: 1826521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of FR115427 against ischemic hippocampal damage in gerbils.
    Nakanishi H; Katsuta K; Koide T; Ueda Y; Shirakawa K; Yoshida K
    Jpn J Pharmacol; 1994 Mar; 64(3):189-93. PubMed ID: 8022120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of 3-carboxy-5-phosphono-1,2,3,4-tetrahydroisoquinoline (SC-48981), a potent competitive N-methy-D-aspartate (NMDA) receptor antagonist, in vitro and in vivo.
    Vazquez ML; Garland DJ; Sun ET; Cler JA; Mick SJ; Hood WF; Monahan JB; Iyengar S; Rao TS
    Neurosci Lett; 1992 Feb; 135(2):149-52. PubMed ID: 1352628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats.
    Millan MJ; Audinot V; Honoré P; Bervoets K; Veiga S; Brocco M
    Eur J Pharmacol; 2000 Jan; 388(1):37-47. PubMed ID: 10657545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro.
    Palmer GC; Harris EW; Ray R; Stagnitto ML; Schmiesing RJ
    Arch Int Pharmacodyn Ther; 1992; 317():16-34. PubMed ID: 1456842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
    Wlaź P; Ebert U; Potschka H; Löscher W
    Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
    Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-methyl-D-aspartate receptor antagonist activity and phencyclidine-like behavioral effects of the pentadecapeptide, [Ser1]histogranin.
    Shukla VK; Lemaire S; Dumont M; Merali Z
    Pharmacol Biochem Behav; 1995 Jan; 50(1):49-54. PubMed ID: 7700954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats.
    Katsuta K; Nakanishi H; Shirakawa K; Yoshida K; Takagi K; Tamura A
    J Cereb Blood Flow Metab; 1995 Mar; 15(2):345-8. PubMed ID: 7860668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice.
    Geter-Douglass B; Witkin JM
    Psychopharmacology (Berl); 1999 Oct; 146(3):280-9. PubMed ID: 10541728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist.
    Baron BM; Harrison BL; Kehne JH; Schmidt CJ; van Giersbergen PL; White HS; Siegel BW; Senyah Y; McCloskey TC; Fadayel GM; Taylor VL; Murawsky MK; Nyce P; Salituro FG
    Eur J Pharmacol; 1997 Apr; 323(2-3):181-92. PubMed ID: 9128837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex.
    Loo PS; Braunwalder AF; Lehmann J; Williams M; Sills MA
    Mol Pharmacol; 1987 Dec; 32(6):820-30. PubMed ID: 2892125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro.
    Murray F; Kennedy J; Hutson PH; Elliot J; Huscroft I; Mohnen K; Russell MG; Grimwood S
    Eur J Pharmacol; 2000 Jun; 397(2-3):263-70. PubMed ID: 10844123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.